1780 Stock Overview
Allied Biotech Corporation manufactures and sells carotenoids worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Allied Biotech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$17.25 |
| 52 Week High | NT$20.70 |
| 52 Week Low | NT$13.50 |
| Beta | -0.021 |
| 1 Month Change | -3.90% |
| 3 Month Change | 9.18% |
| 1 Year Change | -8.97% |
| 3 Year Change | -6.76% |
| 5 Year Change | -3.69% |
| Change since IPO | -3.09% |
Recent News & Updates
Recent updates
Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?
Apr 16
These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well
Mar 05Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment
Jan 24Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?
Jan 03A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)
Dec 13
Is Allied Biotech (GTSM:1780) A Risky Investment?
Nov 25Shareholder Returns
| 1780 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -3.6% | -3.4% | -2.1% |
| 1Y | -9.0% | -25.4% | 27.5% |
Return vs Industry: 1780 exceeded the TW Biotechs industry which returned -25.4% over the past year.
Return vs Market: 1780 underperformed the TW Market which returned 27.5% over the past year.
Price Volatility
| 1780 volatility | |
|---|---|
| 1780 Average Weekly Movement | 3.6% |
| Biotechs Industry Average Movement | 4.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.3% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1780 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1780's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Qing Hui Lin | www.altratene.com |
Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. The company also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage applications; Lutein, a carotenoid that provides a range of green leafed vegetables, such as spinach, kale, broccoli, and egg yolks.; and Nano Coenzyme Q10, an antioxidant, which is used in the transformation of energy in the body.
Allied Biotech Corporation Fundamentals Summary
| 1780 fundamental statistics | |
|---|---|
| Market cap | NT$1.65b |
| Earnings (TTM) | NT$143.79m |
| Revenue (TTM) | NT$736.33m |
11.5x
P/E Ratio2.2x
P/S RatioIs 1780 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1780 income statement (TTM) | |
|---|---|
| Revenue | NT$736.33m |
| Cost of Revenue | NT$462.17m |
| Gross Profit | NT$274.16m |
| Other Expenses | NT$130.37m |
| Earnings | NT$143.79m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.50 |
| Gross Margin | 37.23% |
| Net Profit Margin | 19.53% |
| Debt/Equity Ratio | 72.6% |
How did 1780 perform over the long term?
See historical performance and comparison